NextTrip, Inc. (NTRP)
Market Cap | 3.24M |
Revenue (ttm) | 522,869 |
Net Income (ttm) | -5.92M |
Shares Out | 1.35M |
EPS (ttm) | -10.97 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 10,930 |
Open | 2.500 |
Previous Close | 2.400 |
Day's Range | 2.230 - 2.500 |
52-Week Range | 2.060 - 9.398 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 21, 2024 |
About NTRP
NextTrip, Inc., through its subsidiaries, engages in the provision of travel technology solutions in the United States. The company offers NXT2.0, a booking engine technology platform, which provides travel distributors access to an inventory. It is also involved in the provision of online leisure travel agency services for booking hotels, flights, and curated vacations. The company was formerly known as Sigma Additive Solutions, Inc. and changed its name to NextTrip, Inc. in March 2024. NextTrip, Inc. is based in Sunrise, Florida. [Read more]
Financial Performance
In 2022, NextTrip's revenue was $630,428, a decrease of -61.83% compared to the previous year's $1.65 million. Losses were -$8.75 million, 16.8% more than in 2021.
Financial numbers in USD Financial StatementsNews
NextTrip Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
SUNRISE, FL / ACCESSWIRE / April 2, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip", "we," "our," or the "Company"), a travel technology company, has engaged international investor relations specialis...
Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates
NEW YORK, Nov. 20, 2020 /PRNewswire/ -- Neurotrope, Inc. (NASDAQ: NTRP) ("Neurotrope" or the "Company") announced today that its Board of Directors has approved the conditional distribution and set th...
Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen
NEW YORK and MANALAPAN TOWNSHIP, N.J., Sept. 30, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C., a privately held biopharmaceutical company focused on innova...
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company
NEW YORK and MANALAPAN TOWNSHIP, N.J., May 18, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C., a privately held biopharmaceutical company ("Metuchen"), focus...
Neurotrope Rips 150% Higher On Improved Alzheimer's Data, NIH Funding
Shares of thinly-traded microcap biopharma Neurotrope Inc (NASDAQ: NTRP) gap-opened sharply higher on above 50 times average volume following a corporate update from the company.
Neurotrope's stock plummets on heavy volume after disappointing trial of Alzheimer's treatment
Shares of Neurotrope Inc. NTRP, -77.95% plummeted 79% on heavy volume Monday, to below the $1 mark for the first time in six years, after the biopharmaceutical company said its Alzheimer's disease (AD...
Why Neurotrope Is Plunging On Heavy Volume
Shares of thinly-traded nano-cap biotech Neurotrope Inc (NASDAQ: NTRP) were plummeting Monday following an adverse clinical trial readout.